Jaywin Remedies Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 3.50 M
- Company Age 36 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.57 Cr
- Satisfied Charges ₹ 23.33 Cr
- Revenue Growth 15.02%
- Profit Growth -14.94%
- Ebitda -4.10%
- Net Worth 33.82%
- Total Assets 4.15%
About Jaywin Remedies
Jaywin Remedies Private Limited (JRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 April 1988 and has a history of 36 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹21.57 Cr. The company has closed loans amounting to ₹23.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jaywin Remedies Private Limited India are Ajay Joshi as CFO and Shibu Kurup as Ceo. Shibu Kurup, Ajay Joshi, and Neeta Shirke serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1988PTC010605
- Company No.
010605
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Chemicals and Materials
Pharma
Who are the key members and board of directors at Jaywin Remedies?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Joshi | CFO | 22-Aug-2024 | Current |
| Shibu Kurup | CEO | 22-Aug-2024 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shibu Kurup  | Director | 13-Feb-2007 | Current |
| Ajay Joshi | Director | 13-Feb-2007 | Current |
| Neeta Shirke | Director | 09-Aug-2024 | Current |
Financial Performance of Jaywin Remedies.
Jaywin Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.02% increase. The company also saw a substantial fall in profitability, with a 14.94% decrease in profit. The company's net worth Soared by an impressive increase of 33.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaywin Remedies?
In 2022, Jaywin Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prism Life Sciences LimitedShibu Kurup, Ajay Joshi and 3 more are mutual person
Charges (Loans)
Open Charges
₹215.70 M
Satisfied Charges
₹233.33 M
Charges Breakdown by Lending Institutions
- Others : 21.57 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2024 | Others | ₹9.80 Cr | Open |
| 22 Mar 2024 | Others | ₹4.27 Cr | Open |
| 24 Jan 2024 | Others | ₹7.50 Cr | Open |
| 29 Jul 2023 | Yes Bank Limited | ₹7.10 Cr | Satisfied |
| 07 Nov 2022 | Axis Bank Limited | ₹4.80 Cr | Satisfied |
How Many Employees Work at Jaywin Remedies?
Jaywin Remedies has a workforce of 87 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaywin Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaywin Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
